Genes
-
EPS15 (epidermal growth factor receptor pathway substrate 15)
PICALM (clathrin assembly lymphoid myeloid leukemia gene)
CD151 (CD151 molecule (Raph blood group))
CHIC2 (cystein-rich hydrophobic domain 2)
CLTC (clathrin heavy polypeptide)
CLTCL1 (clathrin heavy polypeptide-like 1)
DYRK1A (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1A)
SH3GL1 (extra eleven nineteen leukemia fusion gene)
EPS8 (epidermal growth factor receptor pathway substrate 8)
FCGR2B (Fc fragment of IgG, low affinity IIb, receptor (CD32))
FCGR2B (Fc fragment of IgG, low affinity IIb, receptor (CD32))
FUT8 (fucosyltransferase 8 (alpha (1,6) fucosyltransferase))
HACE1 (HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1)
SEPT5 (septin 5)
MAL (mal, T-cell differentiation protein)
MARCKS (myristoylated alanine-rich protein kinase C substrate)
STARD3 (START domain containing 3)
MRC1 (mannose receptor, C type 1)
NDRG1 (N-myc downstream regulated 1)
NME1 (NME/NM23 nucleoside diphosphate kinase 1)
NUMB (numb homolog (Drosophila))
PDCD6 (programmed cell death 6)
PIK3R1 (phosphoinositide-3-kinase, regulatory subunit 1 (alpha))
PRSS8 (protease, serine, 8)
REST (RE1-silencing transcription factor)
S100A8 (S100 calcium binding protein A8)
S100A9 (S100 calcium binding protein A9)
SDCBP (syndecan binding protein (syntenin))
SH3GL2 (SH3-domain GRB2-like 2)
SMAP1 (stromal membrane-associated protein 1)
STEAP2 (six transmembrane epithelial antigen of the prostate 2)
TFRC (transferrin receptor (p90, CD71))
THY1 (Thy-1 cell surface antigen)
TPD52 (tumor protein D52)
TRPV2 (transient receptor potential cation channel, subfamily V, member 2)
TSPAN8 (tetraspanin 8)
Figure from CD151
Figure from DYRK1A
Figure from EPS8
Figure from FUT8
Figure from HACE1
Figure from MRC1
Figure from NDRG1
Figure from NUMB
Figure from REST
Figure from SMAP1
Figure from THY1
Figure from TRPV2
Figure from TSPAN8